CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 276.4	$ (971.9)	$ 378.1	$ (988.6)
Other comprehensive (loss) income
Foreign currency translation adjustment	(446.8)	183.0	(440.4)	(41.1)
Unrealized gain on equity method investment, net of tax	4.0	0	22.5	0
Net unrealized holding (loss) gain on available-for-sale equity securities:
Arising in period	(0.9)	0	1.8	3.6
Reclassification to net income (loss)	(1.8)	0	(1.8)	(4.0)
Pension and postretirement benefit plan adjustments	(0.6)	0	(1.8)	0
Other comprehensive (loss) income	(446.1)	183.0	(419.7)	(41.5)
Comprehensive loss	(169.7)	(788.9)	(41.6)	(1,030.1)
Less: Comprehensive income (loss) attributable to noncontrolling interest	2.2	0.7	(1.0)	0.7
Comprehensive loss attributable to Valeant Pharmaceuticals International, Inc.	$ (171.9)	$ (789.6)	$ (40.6)	$ (1,030.8)